 LONDON and CARLSBAD, Calif., Dec. 07, 2020 GLOBE NEWSWIRE -- GW Pharmaceuticals plc NASDAQ: GWPH, GW, the Company or the Group, a world leader in the science, development, and commercialization of cannabinoid prescription medicines, today announced that the Company will present at the Needham Virtual Epilepsy Pain Specialty CNS Therapeutics Conference on Thursday, December 10, 2020 at 11:00am EST. 